Stewart, E;
Tavabie, S;
White, N;
Appleyard, S;
Bass, S;
Gilbert, D;
Herriott, R;
... Minton, O; + view all
(2022)
A short report examining the introduction of routine use of patient reported outcome measures in a mixed oncology population.
Clinical Oncology
, 34
(4)
pp. 241-246.
10.1016/j.clon.2021.11.016.
Preview |
Text
White_clin_onc_publication_combined.pdf - Accepted Version Download (271kB) | Preview |
Abstract
Aims: People living with treatable but not curable cancer often experience a range of symptoms related to their cancer and its treatment. During the COVID-19 pandemic, face-to-face consultations were reduced and so remote monitoring of these needs was necessary. University Hospitals Sussex implemented the routine use of electronic remote patient-reported outcome measures (PROMs) in a mixed oncology population, focusing on those with treatable but not curable cancers. Materials and methods: Over a 9-month period, patients were invited to register with My Clinical Outcomes (MCO) – a secure online platform for the collection of electronic PROMs. They were prompted by e-mail to complete assessments (EORTC QLQ-C30, EQ-5D-3L and EQ-5D VAS) routinely every 2 weeks. The team monitored patient scores and changes in these prompted clinical interventions. Results: In total, 324 patients completed at least one assessment. The median number of assessments completed by each patient was eight. The most represented tumour groups were secondary breast (28%), prostate (25%) and other (32%). Median scores for the assessments did not deteriorate in a clinically or numerically significant way for patients living with non-curable conditions for the majority of patients monitored. Conclusion: Routine collection of electronic remote PROMs is an effective and useful strategy to provide real-time clinical feedback to teams. With integration into existing systems, online platforms (such as MCO) could provide efficient and patient-centred information for those providing care for people with cancer.
Archive Staff Only
 |
View Item |
